Dr. Ajay Gopal on lymphoma innovation, clinical trials and leadership

In this episode, host Petros Grivas, MD, PhD, FASCO, speaks with Ajay Gopal, MD, professor at Fred Hutch Cancer Center and University of Washington and medical director for lymphoma clinical research, for a wide-ranging conversation about the past, present and future of lymphoma care. Gopal holds the Stephen Hans Petersdorf, MD Endowed Chair in Cancer Care at UW Medicine. They cover how clinical trials are changing treatment duration, how translational science is helping overcome immunotherapy resistance and why bringing research closer to patients matters.

Key topics

• A career shaped by lymphoma research, mentorship and immunotherapy

• Using clinical trials to deliver more personalized care

• ctDNA, bispecific antibodies and the next generation of lymphoma treatments

• Tackling treatment resistance through translational science

• Expanding access to research and outpatient cancer care

• AI's potential to accelerate discovery and trial matching

• The future of lymphoma treatment: better outcomes with less therapy

• Leadership lessons and a tribute to mentor Oliver Press, MD, PhD

YouTube | Spotify | Apple Podcasts | Libsyn | Amazon Music